Open | - |
Close | - |
Volume / Avg. | 1.026K / 162.727K |
Day Range | - - - |
52 Wk Range | 0.480 - 1.550 |
Market Cap | $14.663M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 80 |
Short Interest | 5.56% |
Days to Cover | 9.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Imunon (NASDAQ: IMNN) through any online brokerage.
Other companies in Imunon’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH), T2 Biosystems (NASDAQ:TTOO) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for Imunon (NASDAQ: IMNN) was reported by HC Wainwright & Co. on Wednesday, March 13, 2024. The analyst firm set a price target for 12.00 expecting IMNN to rise to within 12 months (a possible 669.23% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Imunon (NASDAQ: IMNN) is $1.56 last updated Today at March 28, 2024 at 4:36 AM EDT.
There are no upcoming dividends for Imunon.
Imunon’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Imunon.
Imunon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.